NMT Technology for Neuromuscular Monitoring

Overseen By Morgan Blazy

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: GE Healthcare

Must be taking: Paralytics

Disqualifiers: Pregnancy, Breastfeeding, Infection, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 1

Duration: Up to 24 hours

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this clinical study is to collect and assess feedback from clinical users regarding the functionality and device use and collection of raw parameter date from the NMT Sensor and NMT Cable.

Are You a Good Fit for This Trial?

This trial is for adults (18+) who need muscle relaxant drugs during a medical procedure and can give written consent. They'll have their muscle function monitored with an NMT ElectroSensor on the hand/forearm.

Inclusion Criteria

Study subject will have the primary NMT monitoring conducted using an NMT ElectroSensor on the hand/forearm

I am 18 years old or older.

Study subject must have the ability to understand and provide written informed consent

Exclusion Criteria

Direct employees or contractors of GE HealthCare, or any company that makes NMT monitoring devices (sensors, cables, modules)

Breastfeeding

Suffering from an infection(s) that requires isolation

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

1-2 weeks

Treatment

Placement of NMT Sensor and collection of feedback during standard of care surgical procedure

Up to 24 hours

1 visit (in-person)

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 months

What Are the Treatments Tested in This Trial?

Interventions

• NMT Technology

Trial Overview

The study is testing the NMT EasyFit Sensor and Cable technology, which monitors neuromuscular function in patients receiving paralytic medication during procedures.

How Is the Trial Designed?

Group I: All Subjects Experimental Treatment 1 Intervention

Placement of NMT Sensor

Who Is Running the Clinical Trial?

GE Healthcare

Lead Sponsor

Trials

307

Recruited

634,000+

Fotis Vlachos

GE Healthcare

Chief Marketing Officer since 2024

PhD in Molecular Biology and Biochemistry from the University of Massachusetts, MBA from the Wharton School of the University of Pennsylvania

Peter J. Arduini

GE Healthcare

Chief Executive Officer since 2022

MBA from Northwestern University, BSc in Marketing from Susquehanna University

Loma Linda University

Collaborator

Trials

322

Recruited

267,000+